Loss of Filamin C is Catastrophic for Heart Function
Yangzhao Zhou,Ze’e Chen,Lunfeng Zhang,Mason Zhu,Changming Tan,Xinmin Zhou,Sylvia M. Evans,Xi Fang,Wei Feng,Ju Chen
DOI: https://doi.org/10.1161/circulationaha.119.044061
IF: 37.8
2020-01-01
Circulation
Abstract:HomeCirculationVol. 141, No. 10Loss of Filamin C Is Catastrophic for Heart Function Free AccessLetterPDF/EPUBAboutView PDFView EPUBSections ToolsAdd to favoritesDownload citationsTrack citationsPermissions ShareShare onFacebookTwitterLinked InMendeleyReddit Jump toFree AccessLetterPDF/EPUBLoss of Filamin C Is Catastrophic for Heart Function Yangzhao Zhou, MD, Ze'e Chen, BS, Lunfeng Zhang, PhD, Mason Zhu, BS, Changming Tan, MD, PhD, Xinmin Zhou, MD, PhD, Sylvia M. Evans, PhD, Xi Fang, PhD, Wei Feng, MD, PhD and Ju Chen, PhD Yangzhao ZhouYangzhao Zhou Departments of Medicine–Cardiology (Y.Z., Z.C., L.Z., M.Z., C.T., S.M.E., X.F., W.F., J.C.), University of California San Diego, La Jolla. Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China (Y.Z., C.T., X.Z.). , Ze'e ChenZe'e Chen Departments of Medicine–Cardiology (Y.Z., Z.C., L.Z., M.Z., C.T., S.M.E., X.F., W.F., J.C.), University of California San Diego, La Jolla. , Lunfeng ZhangLunfeng Zhang Departments of Medicine–Cardiology (Y.Z., Z.C., L.Z., M.Z., C.T., S.M.E., X.F., W.F., J.C.), University of California San Diego, La Jolla. , Mason ZhuMason Zhu Departments of Medicine–Cardiology (Y.Z., Z.C., L.Z., M.Z., C.T., S.M.E., X.F., W.F., J.C.), University of California San Diego, La Jolla. , Changming TanChangming Tan Departments of Medicine–Cardiology (Y.Z., Z.C., L.Z., M.Z., C.T., S.M.E., X.F., W.F., J.C.), University of California San Diego, La Jolla. Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China (Y.Z., C.T., X.Z.). , Xinmin ZhouXinmin Zhou Department of Cardiovascular Surgery, The Second Xiangya Hospital, Central South University, Changsha, Hunan, China (Y.Z., C.T., X.Z.). , Sylvia M. EvansSylvia M. Evans Departments of Medicine–Cardiology (Y.Z., Z.C., L.Z., M.Z., C.T., S.M.E., X.F., W.F., J.C.), University of California San Diego, La Jolla. Pharmacology (S.M.E.), University of California San Diego, La Jolla. Skaggs School of Pharmacy and Pharmaceutical Sciences (S.M.E.), University of California San Diego, La Jolla. , Xi FangXi Fang Departments of Medicine–Cardiology (Y.Z., Z.C., L.Z., M.Z., C.T., S.M.E., X.F., W.F., J.C.), University of California San Diego, La Jolla. , Wei FengWei Feng Departments of Medicine–Cardiology (Y.Z., Z.C., L.Z., M.Z., C.T., S.M.E., X.F., W.F., J.C.), University of California San Diego, La Jolla. and Ju ChenJu Chen Ju Chen, PhD, Department of Medicine–Cardiology, University of California San Diego, 9500 Gilman Drive, Mail Code 0613-C, La Jolla, CA 92093. Email E-mail Address: [email protected] Departments of Medicine–Cardiology (Y.Z., Z.C., L.Z., M.Z., C.T., S.M.E., X.F., W.F., J.C.), University of California San Diego, La Jolla. Originally published9 Mar 2020https://doi.org/10.1161/CIRCULATIONAHA.119.044061Circulation. 2020;141:869–871Mutations in filamin C (FLNC) are associated with different forms of cardiomyopathies.1,2 The role of FLNC in mammalian cardiomyocytes remains largely unexplored. FLNC is expressed predominantly in striated muscle, localizing to Z-discs, intercalated discs (ICDs), and costameres.3 Mice expressing a C-terminal truncated FLNC mutant protein display perinatal lethality with severe defects in skeletal myogenesis but no cardiac defects.4 The latter is puzzling, given that multiple distinct FLNC mutations lead to cardiomyopathy. Because this mutant Flnc allele might be hypomorphic, a true null Flnc and an Flnc cardiomyocyte-specific knockout model are essential to investigate requirements for Flnc in cardiomyocytes fully.We generated Flnc global knockout and cardiac-specific knockout mice by crossing Sox2-Cre or cardiac troponin T-Cre to FLNC-floxed mice (Flnctm1a[EUCOMM]Hmgu),in which exons 9 through 13 of Flnc are flanked by 2 LoxP sites. Cre-mediated deletion results in loss of the Flnc region between exons 9 and 13, frameshift of Flnc, and subsequent loss of the protein. All mouse protocols were approved by the Institutional Animal Care and Use Committee. Both global knockout and cardiac-specific knockout mice were embryonic lethal, demonstrating that Flnc is critical in developing cardiomyocytes (data not shown).To study Flnc in adult cardiomyocytes, we generated icKO mice (inducible cardiomyocyte-specific knockout) by crossing Flnc-floxed mice with αMHC-MerCreMer mice and subjected them to tamoxifen treatment (TAM) at 2 months of age. FLNC protein was efficiently ablated in icKO mouse hearts 2 weeks after TAM (Figure [A and B]). Flnc-icKO mice began to die 1 week after TAM, with 73% dying by 25 weeks (Figure [C]). No icKO mice survived past 60 weeks of age (Figure [C]). icKO hearts at 2 weeks and 6 weeks after TAM displayed marked cardiac dilation and extensive fibrosis 6 weeks after TAM (Figure [D]). Analysis of heart weight to body weight ratios revealed significantly increased heart mass in icKO mice at 2 weeks after TAM compared with control mice, whereas no differences were observed in body weight. Cardiac stress markers Anf, Bnp, and Myh7 were significantly increased in icKO hearts at 2 weeks after TAM, as were profibrotic genes Col1a1 and Col3a1 (Figure [F]).Download figureDownload PowerPointFigure. Loss of filamin C is catastrophic for heart function.A and B, Representative Western blot (A) and quantitation (B) showing efficient loss of Flnc in icKO mouse (inducible cardiomyocyte-specific knockout) hearts 2 weeks after tamoxifen treatment (TAM) (40 mg/kg/d for 3 days). Flncf/f;Cre− littermates after TAM served as controls (Ctrl). Three mice per group were included. C, Kaplan-Meier survival curves of Flncf/f and Flncf/f;Cre+ mice injected with TAM or vehicle control (n=16, 8, 26, and 9, respectively). D, Microscopic cross-sectional views of hematoxylin & eosin (left; scale bar, 1 mm) and Masson trichrome (right; scale bar: 50 μm) stained hearts isolated from Flnc icKO or Ctrl mice, 2 weeks or 6 weeks after TAM (n=3). E, Heart weight to body weight (HW/BW) ratio for icKO (n=14) and Ctrl (n=12) mice 2 weeks after TAM. F, Quantitative real-time polymerase chain reaction analysis in Ctrl and icKO mouse hearts at 2 weeks after TAM. G, Representative echocardiographic images of icKO and Ctrl mice at 2 and 4 weeks after TAM. H through J, Echocardiographic measurements for Flncf/f and Flncf/f;Cre+ mice at baseline or 2, 4, or 8 weeks after TAM or vehicle control (n=8, 4, 15, and 5, respectively). K, Diagram of intercalated disc (ICD), Z-disc, and costamere components. Proteins noted in red were upregulated, whereas those in black were unchanged, in Flnc icKO hearts. L through P, Representative Western blots and quantification of integrin complex, DGC (dystrophin-associated glycoprotein complex) proteins, Z-disk protein, and desmin and ICD components in icKO and Ctrl hearts at 2 weeks after TAM (n=3). Other than FAK (focal adhesion kinase), δ-SAG (1-stearoyl-2-arachidonoyl-sn-glycerol), β-DSG (disuccinimidyl glutarate), and dystrophin, which were not detected in our mass spectrometry studies, all other proteins tested in the Western blot analysis have similar changes in mass spectrometry studies. Q, Quantitative real-time polymerase chain reaction analysis for mRNAs of proteins examined in Ctrl and icKO mouse hearts at 2 weeks after TAM injection. R, Functional enrichment analysis of proteins upregulated in icKO. For Western blot analysis, GAPDH served as a loading control. The pixel density of each protein was normalized to the level of GAPDH. In quantitative real-time polymerase chain reaction assays, mRNA levels of each gene were normalized to corresponding 18S levels, with icKO values being expressed as fold change versus control. Data are mean±SEM. CAR indicates Coxsackievirus–adenovirus receptor; DSP, dithiobis(succinimidyl propionate); ECM, extracellular matrix; ENH, enigma homolog; FLNC, Filamin C; FS, fractional shortening; ILK, integrin-linked kinase; JUP, junction plakoglobin; LIMP-2, lysosomal integral membrane protein; LVIDd, end-diastolic left ventricle internal diameter; LVIDs, end-systolic left ventricle internal diameter; MLP, muscle LIM protein; PINCH, particularly interesting new cysteine-histidine-rich protein; PKP2, plakophilin-2; T-cap, telethonin; and ZO-1, zonula occludens–1. *P<0.05 by 2-tailed Student t test.Echocardiographic studies revealed a rapid and progressive decrease in left ventricular systolic function (fractional shortening) in icKO mice relative to control mice (Figure [G and H]). Left ventricular chamber dilation was shown by a significant increase in end-diastolic left ventricle internal diameter and end-systolic left ventricle internal diameter (Figure [I and J]).FLNC interacts with multiple cytoskeletal proteins, including integrins and the dystrophin-associated glycoprotein complex at the costamere, myotilin and FATZ-1 at the Z-disk, and Xin proteins at the ICD.3 We investigated whether loss of Flnc in cardiomyocytes affected levels of major cytoskeletal proteins comprising these complexes (Figure [K through P]).5 Loss of Flnc resulted in significant increases in β1D-integrin, as well as Talin1, Kindlin2, FAK (focal adhesion kinase), vinculin, and ILK (integrin-linked kinase), whereas paxillin was not changed (Figure [L]). δ- and γ-SAG (1-stearoyl-2-arachidonoyl-sn-glycerol), dystrophin, and β-DSG (disuccinimidyl glutarate), but not α-DSG, were increased in icKO hearts (Figure [M]). Desmin, an intermediate filament protein, was also increased. Z-disc proteins myotilin, FATZ-1, α-actinin, and Cypher were not changed (Figure [N]). ICD proteins Xirp1 and Xirp2, JUP (junction plakoglobin), and DSP (dithiobis[succinimidyl propionate]) were significantly increased, whereas PKP2 (plakophilin-2) and DSG2 were not changed (Figure [O]). These results demonstrate that loss of Flnc resulted in increased levels of a subset of costameric and ICD proteins (Figure [P]). Quantitative real-time polymerase chain reaction data indicated that mRNA levels of increased proteins were not changed, with the exception of Xirp1 and Xirp2 mRNA levels, which were significantly increased (Figure [Q]). Immunostaining for upregulated proteins showed no protein aggregation or mislocalization in icKO hearts (data not shown).Mass spectrometry analysis identified 380 proteins that were upregulated more than 2-fold and 27 proteins that were downregulated more than 2-fold in icKO hearts relative to control hearts. These data confirm increased levels of specific proteins found by initial Western blot analyses. Functional clustering of upregulated proteins revealed the most significant pathway enrichment in cytoskeletal protein binding, actin binding, and extracellular matrix structural constituent (Figure [R]).Previous mutation of Flnc in mice resulted in defects in skeletal muscle development, with no evident cardiac phenotype,4 despite the observation that recessive mutations in FLNC lead to human congenital dilated cardiomyopathy.1,2 Our results have addressed this apparent contradiction by demonstrating a key and critical role for FLNC in both developing and adult cardiomyocytes. In embryonic cardiomyocytes, loss of FLNC resulted in fetal death. In adult cardiomyocytes, upon loss of FLNC, mice developed rapid and fulminant dilated cardiomyopathy within 2 weeks. Loss of FLNC was accompanied by upregulation of multiple proteins, including those that directly interact with FLNC, representing components of the costamere and ICD, and the intermediate filament protein Desmin (Figure [K]). The dire effects of loss of FLNC are likely to reflect its significant effect on all 3 of these major constituents of the cardiomyocyte cytoskeleton, which are essential for normal contraction.Sources of FundingDrs J. Chen, Fang, and Evans are funded by grants from the National Heart, Lung, and Blood Institute of the US National Institutes of Health. Dr J. Chen holds an American Heart Association Endowed Chair in Cardiovascular Research. M. Zhu was supported by an American Heart Association Summer Undergraduate Fellowship.DisclosuresNone.Footnotes*Drs Fang, Feng, and J. Chen contributed equally.https://www.ahajournals.org/journal/circThe data, analytical methods, and study materials that support the findings of this study will be available to other researchers from the corresponding authors on reasonable request.Ju Chen, PhD, Department of Medicine–Cardiology, University of California San Diego, 9500 Gilman Drive, Mail Code 0613-C, La Jolla, CA 92093. Email [email protected]eduReferences1. Ader F, De Groote P, Réant P, Rooryck-Thambo C, Dupin-Deguine D, Rambaud C, Khraiche D, Perret C, Pruny JF, Mathieu-Dramard M, et al. FLNC pathogenic variants in patients with cardiomyopathies: prevalence and genotype-phenotype correlations.Clin Genet. 2019; 96:317–329. doi: 10.1111/cge.13594CrossrefMedlineGoogle Scholar2. Reinstein E, Gutierrez-Fernandez A, Tzur S, Bormans C, Marcu S, Tayeb-Fligelman E, Vinkler C, Raas-Rothschild A, Irge D, Landau M, et al. Congenital dilated cardiomyopathy caused by biallelic mutations in Filamin C.Eur J Hum Genet. 2016; 24:1792–1796. doi: 10.1038/ejhg.2016.110CrossrefMedlineGoogle Scholar3. van der Ven PF, Ehler E, Vakeel P, Eulitz S, Schenk JA, Milting H, Micheel B, Fürst DO. Unusual splicing events result in distinct Xin isoforms that associate differentially with filamin C and Mena/VASP.Exp Cell Res. 2006; 312:2154–2167. doi: 10.1016/j.yexcr.2006.03.015CrossrefMedlineGoogle Scholar4. Dalkilic I, Schienda J, Thompson TG, Kunkel LM. Loss of FilaminC (FLNc) results in severe defects in myogenesis and myotube structure.Mol Cell Biol. 2006; 26:6522–6534. doi: 10.1128/MCB.00243-06CrossrefMedlineGoogle Scholar5. Zhang Z, Mu Y, Zhang J, Zhou Y, Cattaneo P, Veevers J, Peter AK, Manso AM, Knowlton KU, Zhou X, et al. Kindlin-2 is essential for preserving integrity of the developing heart and preventing ventricular rupture.Circulation. 2019; 139:1554–1556. doi: 10.1161/CIRCULATIONAHA.118.038383LinkGoogle Scholar Previous Back to top Next FiguresReferencesRelatedDetailsCited By Song S, Shi A, Lian H, Hu S and Nie Y (2021) Filamin C in cardiomyopathy: from physiological roles to DNA variants, Heart Failure Reviews, 10.1007/s10741-021-10172-z, 27:4, (1373-1385), Online publication date: 1-Jul-2022. Brodehl A and Gerull B (2022) Genetic Insights into Primary Restrictive Cardiomyopathy, Journal of Clinical Medicine, 10.3390/jcm11082094, 11:8, (2094) Chen S, Lam C, Wan Y, Gao S, Malak O, Zhao S, Lombardi R, Ambardekar A, Bristow M, Cleveland J, Gigli M, Sinagra G, Graw S, Taylor M, Wu J and Mestroni L (2022) Activation of PDGFRA signaling contributes to filamin C–related arrhythmogenic cardiomyopathy, Science Advances, 10.1126/sciadv.abk0052, 8:8, Online publication date: 25-Feb-2022. Bang M, Bogomolovas J and Chen J (2022) Understanding the molecular basis of cardiomyopathy, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00562.2021, 322:2, (H181-H233), Online publication date: 1-Feb-2022. Celeghin R, Cipriani A, Bariani R, Bueno Marinas M, Cason M, Bevilacqua M, De Gaspari M, Rizzo S, Rigato I, Da Pozzo S, Zorzi A, Perazzolo Marra M, Thiene G, Iliceto S, Basso C, Corrado D, Pilichou K and Bauce B (2022) Filamin-C variant-associated cardiomyopathy: A pooled analysis of individual patient data to evaluate the clinical profile and risk of sudden cardiac death, Heart Rhythm, 10.1016/j.hrthm.2021.09.029, 19:2, (235-243), Online publication date: 1-Feb-2022. Powers J and McCulloch A (2022) Biomechanical signals regulating the structure of the heart, Current Opinion in Physiology, 10.1016/j.cophys.2021.100482, 25, (100482), Online publication date: 1-Feb-2022. Powers J, Kirkland N, Liu C, Razu S, Fang X, Engler A, Chen J and McCulloch A (2022) Subcellular Remodeling in Filamin C Deficient Mouse Hearts Impairs Myocyte Tension Development during Progression of Dilated Cardiomyopathy, International Journal of Molecular Sciences, 10.3390/ijms23020871, 23:2, (871) Qin Z, Sun L, Sun X, Su H and Gao X (2021) A CRISPR/Cas9 strategy for the generation of a FLNC knockout hESC line (WAe009-A-70) to model dilated cardiomyopathy and arrhythmogenic right ventricular cardiomyopathy, Stem Cell Research, 10.1016/j.scr.2021.102562, 56, (102562), Online publication date: 1-Oct-2021. Agarwal R, Paulo J, Toepfer C, Ewoldt J, Sundaram S, Chopra A, Zhang Q, Gorham J, DePalma S, Chen C, Gygi S, Seidman C and Seidman J (2021) Filamin C Cardiomyopathy Variants Cause Protein and Lysosome Accumulation, Circulation Research, 129:7, (751-766), Online publication date: 17-Sep-2021. Tan C, Zhu S, Chen Z, Liu C, Li Y, Zhu M, Zhang Z, Zhang Z, Zhang L, Gu Y, Liang Z, Boyer T, Ouyang K, Evans S, Fang X and Firulli A (2021) Mediator complex proximal Tail subunit MED30 is critical for Mediator core stability and cardiomyocyte transcriptional network, PLOS Genetics, 10.1371/journal.pgen.1009785, 17:9, (e1009785) Schänzer A, Schumann E, Zengeler D, Gulatz L, Maroli G, Ahting U, Sprengel A, Gräf S, Hahn A, Jux C, Acker T, Fürst D, Rupp S, Schuld J and van der Ven P (2021) The p.Ala2430Val mutation in filamin C causes a "hypertrophic myofibrillar cardiomyopathy", Journal of Muscle Research and Cell Motility, 10.1007/s10974-021-09601-1, 42:2, (381-397), Online publication date: 1-Jun-2021. Arif M, Klevstig M, Benfeitas R, Doran S, Turkez H, Uhlén M, Clausen M, Wikström J, Etal D, Zhang C, Levin M, Mardinoglu A and Boren J (2021) Integrative transcriptomic analysis of tissue-specific metabolic crosstalk after myocardial infarction, eLife, 10.7554/eLife.66921, 10 Wadmore K, Azad A and Gehmlich K (2021) The Role of Z-disc Proteins in Myopathy and Cardiomyopathy, International Journal of Molecular Sciences, 10.3390/ijms22063058, 22:6, (3058) Eden M and Frey N (2021) Cardiac Filaminopathies: Illuminating the Divergent Role of Filamin C Mutations in Human Cardiomyopathy, Journal of Clinical Medicine, 10.3390/jcm10040577, 10:4, (577) Schuld J, Orfanos Z, Chevessier F, Eggers B, Heil L, Uszkoreit J, Unger A, Kirfel G, van der Ven P, Marcus K, Linke W, Clemen C, Schröder R and Fürst D (2020) Homozygous expression of the myofibrillar myopathy-associated p.W2710X filamin C variant reveals major pathomechanisms of sarcomeric lesion formation, Acta Neuropathologica Communications, 10.1186/s40478-020-01001-9, 8:1, Online publication date: 1-Dec-2020. Guo H, Lu Y, Lin Z, Huang Z, Liu J, Wang Y, Seok H, Hu X, Ma Q, Li K, Kyselovic J, Wang Q, Lin J, Lin J, Cowan D, Naya F, Chen Y, Pu W and Wang D (2020) Intercalated disc protein Xinβ is required for Hippo-YAP signaling in the heart, Nature Communications, 10.1038/s41467-020-18379-8, 11:1, Online publication date: 1-Dec-2020. Lamsoul I, Dupré L and Lutz P (2020) Molecular Tuning of Filamin A Activities in the Context of Adhesion and Migration, Frontiers in Cell and Developmental Biology, 10.3389/fcell.2020.591323, 8 Knyazeva A, Khudiakov A, Vaz R, Muravyev A, Sukhareva K, Sejersen T and Kostareva A (2020) FLNC Expression Level Influences the Activity of TEAD-YAP/TAZ Signaling, Genes, 10.3390/genes11111343, 11:11, (1343) Pecorari I, Mestroni L and Sbaizero O (2020) Current Understanding of the Role of Cytoskeletal Cross-Linkers in the Onset and Development of Cardiomyopathies, International Journal of Molecular Sciences, 10.3390/ijms21165865, 21:16, (5865) Pruna M and Ehler E (2020) The intercalated disc: a mechanosensing signalling node in cardiomyopathy, Biophysical Reviews, 10.1007/s12551-020-00737-x, 12:4, (931-946), Online publication date: 1-Aug-2020. Gerull B and Brodehl A (2020) Genetic Animal Models for Arrhythmogenic Cardiomyopathy, Frontiers in Physiology, 10.3389/fphys.2020.00624, 11 Bogomolovas J, Feng W, Yu M, Huang S, Zhang L, Trexler C, Gu Y, Spinozzi S and Chen J (2020) Atypical ALPK2 kinase is not essential for cardiac development and function, American Journal of Physiology-Heart and Circulatory Physiology, 10.1152/ajpheart.00249.2020, 318:6, (H1509-H1515), Online publication date: 1-Jun-2020. March 10, 2020Vol 141, Issue 10 Advertisement Article InformationMetrics © 2020 American Heart Association, Inc.https://doi.org/10.1161/CIRCULATIONAHA.119.044061PMID: 32150467 Originally publishedMarch 9, 2020 Keywordsmutationfilaminsmyocytes, cardiaccardiomyopathyPDF download Advertisement SubjectsCardiomyopathyHeart Failure